Source: MarketScreener

AnGes: AnGes : Notice Regarding the Decision to Sell the ZOKINVY Business of Eiger BioPharmaceuticals, Inc.

(marketscreener.com) May 8, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Notice Regarding the Decision to Sell the ZOKINVY Business of Eiger BioPharmaceuticals, Inc. AnGes Inc. announced on April 12, 2024 that...https://www.marketscreener.com/quote/stock/ANGES-INC-6814797/news/AnGes-Notice-Regarding-the-Decision-to-Sell-the-ZOKINVY-Business-of-Eiger-BioPharmaceuticals-Inc-46661338/?utm_medium=RSS&utm_content=20240508

Read full article »
AnGes's Competitors | AnGes's News | AnGes's Financials
Stay up-to-date with the latest news on AnGes
Annual Revenue
$100K-5.0M
Employees
25-100
Yamada Ei's photo - President & CEO of AnGes

President & CEO

Yamada Ei

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on AnGes